Patrys To Commence PAT-SM6 Melanoma Clinical Trial
Patrys said that an application for approval to commence a human clinical trial for PAT-SM6 has been lodged with Australian authorities, with the aim of initiating the trial
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
PerkinElmer and Abbott’s presentation will be based on their work together incorporating PerkinElmer’s exact mass TOF technology as part of Abbott’s Plex-ID detection platform, employed in pathogen detection
Spectrum Chemicals & Laboratory Products manufactures and distributes fine chemicals and laboratory products. Spectrum’s chemical offering consists of over 15,000 active pharmaceutical ingredients (API’s), excipients, biochemicals, nutraceuticals, cosmetic
MS Workstation 7 features Scheduled Multiple-Reaction Monitoring (s-MRM), which facilitates method development, maintenance and data reduction tasks for challenging multi-component methods. Bruker has said that to answer the
According to the eClinicalWorks, the solution includes unified electronic medical records (EMR) and practice management (PM) solution, Electronic Health eXchange (eEHX), Patient Portal, Enterprise Business Optimizer (eBO), eClinicalMobile